Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women.
OBJECTIVE
We investigated the effects of mineral water fortified with folic acid, vitamins B(6), B(12), D and calcium on folate concentrations in serum and erythrocytes, serum vitamin B(12) and plasma homocysteine concentrations in free-living subjects. In addition, we investigated the bioavailability of calcium added to mineral water by measuring urinary calcium excretion and serum alkaline phosphatase activity.


METHODS
Randomized, controlled, double-blinded, parallel design.


METHODS
Outpatient dietary intervention with free-living subjects in Eastern Finland.


METHODS
Altogether, 66 subjects were recruited for the study. In all, 60 subjects completed the study.


METHODS
The study began with a 2-week run-in period followed by an 8-week intervention period. During the intervention study, subjects consumed mineral water fortified with folic acid (563 microg/day), vitamins B(6) (1 mg/day), B(12) (7.5 microg/day), cholecalciferol (0.6 microg/day) and calcium (563 mg/day) or placebo mineral water.


RESULTS
The fortified mineral water increased serum and erythrocyte folate concentrations by 16.1+/-5.6 nmol/l (P<0.001) and 199+/-76 nmol/l (P<0.001), respectively, and decreased plasma homocysteine concentration by 1.6 micromol/l (P<0.001). Urinary calcium excretion and serum alkaline phosphatase activity for 24 h increased significantly (P<0.001 and P=0.01 respectively) in the intervention group.


CONCLUSIONS
Mineral water fortified with folic acid, vitamins B(6), B(12) and D and calcium enhanced folate status and reduced plasma homocysteine concentration in normohomocysteinemic subjects without folate deficiency. Indirect measures of calcium and bone metabolism indicated that the calcium used in the fortification of the mineral water was bioavailable.
Tapola
N S
NS
Contract research organization, Oy Foodfiles Ltd, Kuopio, Finland. niina.tapola@foodfiles.com
Karvonen
H M
HM
Niskanen
L K
LK
Sarkkinen
E S
ES
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002136:Calcium, Dietary / Q000008:administration & dosage* / Q000097:blood / Q000652:urine; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage* / Q000097:blood; D005527:Food, Fortified; D006710:Homocysteine / Q000097:blood / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D008900:Mineral Waters / Q000008:administration & dosage* / Q000032:analysis; D014803:Vitamin B Complex / Q000008:administration & dosage* / Q000097:blood; D014807:Vitamin D / Q000008:administration & dosage* / Q000097:blood
D002136:Calcium, Dietary; D008900:Mineral Waters; D006710:Homocysteine; D014803:Vitamin B Complex; D014807:Vitamin D; D005492:Folic Acid